GSK Investigational Site

Melbourne, Victoria

We've found

3 trials

at this facility

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Melbourne,

First Time in Humans (FTIH) Study of GSK3368715 in Subjects With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Melbourne,

Phase 1 First Time in Humans (FTIH), Open Label Study of GSK3745417 Administered to Subjects With Advanced Solid Tumors

Status: Upcoming, Phase I
Updated: 12/31/1969

from

Melbourne,

Use our guide to learn which trials are right for you!